Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166816
Status:
UNKNOWN
Last Update Posted:
2005-09-14
First Post:
2005-09-12
Brief Title:
The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
The Pharmacokinetics and Dosage Regimen of Sirolimus in a Cyclosporine or Tacrolimus-Based Immunosuppression in Renal Transplant Patients
Status:
UNKNOWN
Status Verified Date:
2001-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to understand the pharmacokinetic of sirolimus in different regimens as well as the dose-level relationship of cyclosporine and tacrolimus and design the most appropriate cyclosporinesirolimussteroid or tacrolimussirolimussteroid dose regimen for Taiwanese
Detailed Description:
The dose and pharmacokinetic of an immunosuppressant may differ in different ethnics and different combinations
The purpose of this study is to determine the dose-level relationship of sirolimus through pharmacokinetic study The dose-level relationship of cyclosporine and tacrolimus was also assessed From clinical outcome and blood level of sirolimus and cyclosporine or tacrolimus we can design the most appropriate cyclosporinesirolimussteroid or tacrolimussirolimussteroid dose regimen for Taiwanese
The purpose of this study is to determine the dose-level relationship of sirolimus through pharmacokinetic study The dose-level relationship of cyclosporine and tacrolimus was also assessed From clinical outcome and blood level of sirolimus and cyclosporine or tacrolimus we can design the most appropriate cyclosporinesirolimussteroid or tacrolimussirolimussteroid dose regimen for Taiwanese
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NTUH S010 | None | None | None |